Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 14;25(2):221-223.
doi: 10.1093/neuonc/noac247.

The NCI Glioblastoma Therapeutics Network (GTN)

Suzanne Forry  1 , Leah Hubbard  1 , Michael G Espey  1 , Bhadrasain Vikram  1 , Bhupinder Mann  1 , Abdul Tawab-Amiri  2 , Toby Hecht  1
Affiliations

The NCI Glioblastoma Therapeutics Network (GTN)

Suzanne Forry et al. Neuro Oncol. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Structure of the Glioblastoma Therapeutics Network (GTN): five U19 Center grants include two or three Projects (red discs), one or two Cores (blue discs), and an Administrative Core (lavender disc). Light blue boxes next to each U19 Center include names of PI(s) and their institutions (red) and the title of the U19 grant. The Network Coordination Center (NCC, gray disc) is located at Mayo Rochester. The NCC interacts administratively with all U19 Centers (green arrows). Cross-U19 activities (black arrows) include Collaborative Pilot Projects, sharing of resources, and shared clinical studies. The Steering Committee is central in assessing transit of therapeutic agents from pre-clinical to clinical studies.
See this image and copyright information in PMC

References

    1. Grossman SA, Romo CG, Rudek MA, et al. ; Baseline requirements for novel agents being considered for phase II/III brain cancer efficacy trials: conclusions from the Adult Brain Tumor Consortium’s first workshop on CNS drug delivery. Neuro Oncol. 2020;22(10):1422–1424. - PMC - PubMed
    1. National Cancer Institute Clinical Trials and Translational Research Advisory Committee (CTAC), Glioblastoma (GBM) Working Group, Working Group Report. July 17, 2019. Available at https://deainfo.nci.nih.gov/advisory/ctac/0719/Att_12_GBM%20WG%20Final%2.... Accessed November 2022.
    1. RFA-CA-20-047, Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required). August 27, 2020. Available at https://grants.nih.gov/grants/guide/rfa-files/rfa-ca-20-047.html. Accessed November 2022.
    1. Glioblastoma Therapeutics Network. 2022. Available at http://www.gbmnetwork.org. Accessed November 2022.

Publication types